Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib

Vincenzo Marotta; Carolina Di Somma; Manila Rubino; Concetta Sciammarella; Roberta Modica; Luigi Camera; Michela Del Prete; Francesca Marciello; Valeria Ramundo; Luisa Circelli; Pasqualina Buonomano; Annamaria Colao; Antongiulio Faggiano

doi:10.1007/s12020-014-0448-y

Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib

Vincenzo Marotta, Carolina Di Somma, Manila Rubino, Concetta Sciammarella, Roberta Modica, Luigi Camera, Michela Del Prete, Francesca Marciello, Valeria Ramundo, Luisa Circelli, Pasqualina Buonomano, Annamaria Colao, Antongiulio Faggiano

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	854-858
Number of pages	5
Journal	Endocrine
Volume	49
Issue number	3
DOIs	https://doi.org/10.1007/s12020-014-0448-y
Publication status	Published - Aug 27 2015

ASJC Scopus subject areas

Endocrinology
Endocrinology, Diabetes and Metabolism

Access to Document

10.1007/s12020-014-0448-y

Cite this

Marotta, V., Di Somma, C., Rubino, M., Sciammarella, C., Modica, R., Camera, L., Del Prete, M., Marciello, F., Ramundo, V., Circelli, L., Buonomano, P., Colao, A., & Faggiano, A. (2015). Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib. Endocrine, 49(3), 854-858. https://doi.org/10.1007/s12020-014-0448-y

Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib. / Marotta, Vincenzo; Di Somma, Carolina; Rubino, Manila; Sciammarella, Concetta; Modica, Roberta; Camera, Luigi; Del Prete, Michela; Marciello, Francesca; Ramundo, Valeria; Circelli, Luisa; Buonomano, Pasqualina; Colao, Annamaria; Faggiano, Antongiulio.

In: Endocrine, Vol. 49, No. 3, 27.08.2015, p. 854-858.

Research output: Contribution to journal › Article › peer-review

Marotta, V, Di Somma, C, Rubino, M, Sciammarella, C, Modica, R, Camera, L, Del Prete, M, Marciello, F, Ramundo, V, Circelli, L, Buonomano, P, Colao, A & Faggiano, A 2015, 'Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib', Endocrine, vol. 49, no. 3, pp. 854-858. https://doi.org/10.1007/s12020-014-0448-y

Marotta, Vincenzo ; Di Somma, Carolina ; Rubino, Manila ; Sciammarella, Concetta ; Modica, Roberta ; Camera, Luigi ; Del Prete, Michela ; Marciello, Francesca ; Ramundo, Valeria ; Circelli, Luisa ; Buonomano, Pasqualina ; Colao, Annamaria ; Faggiano, Antongiulio. / Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib. In: Endocrine. 2015 ; Vol. 49, No. 3. pp. 854-858.

@article{69d6446b7318453f8ef49e711a3f5dcd,

title = "Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib",

author = "Vincenzo Marotta and {Di Somma}, Carolina and Manila Rubino and Concetta Sciammarella and Roberta Modica and Luigi Camera and {Del Prete}, Michela and Francesca Marciello and Valeria Ramundo and Luisa Circelli and Pasqualina Buonomano and Annamaria Colao and Antongiulio Faggiano",

year = "2015",

month = aug,

day = "27",

doi = "10.1007/s12020-014-0448-y",

language = "English",

volume = "49",

pages = "854--858",

journal = "Endocrine",

issn = "1355-008X",

publisher = "Humana Press Inc.",

number = "3",

}

TY - JOUR

T1 - Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib

AU - Marotta, Vincenzo

AU - Di Somma, Carolina

AU - Rubino, Manila

AU - Sciammarella, Concetta

AU - Modica, Roberta

AU - Camera, Luigi

AU - Del Prete, Michela

AU - Marciello, Francesca

AU - Ramundo, Valeria

AU - Circelli, Luisa

AU - Buonomano, Pasqualina

AU - Colao, Annamaria

AU - Faggiano, Antongiulio

PY - 2015/8/27

Y1 - 2015/8/27

UR - http://www.scopus.com/inward/record.url?scp=84937948975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937948975&partnerID=8YFLogxK

U2 - 10.1007/s12020-014-0448-y

DO - 10.1007/s12020-014-0448-y

M3 - Article

C2 - 25305056

AN - SCOPUS:84937948975

VL - 49

SP - 854

EP - 858

JO - Endocrine

JF - Endocrine

SN - 1355-008X

IS - 3

ER -

Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this